semaglutide mash GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT FOR SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, is now the first GLP-1 therapy approved to treat (Metabolic Dysfunction–Associated Hepatoprotective effects of semaglutide and

Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Circadian rhythm of homocysteine: A study in healthy adults showed that homocysteine levels vary by about 3mol/L over the course of a day

These findings have led to NICE recommendations supporting the use of certain GLP-1 receptor agonists in patients with type 2 diabetes and established cardiovascular disease or at high cardiovascular risk

Importantly, the vast majority of the available PCOS models are generated by exogenous administration of androgens during specific developmental windows, which hampers evaluation of the effects of treatments on endogenous androgen secretion and ovarian function

Kansanen et al., 2013)

Wegovy Ozempic and Wegovy both contain the same active ingredient, semaglutide